27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Allergan (NYSE: AGN) shares are trading higher by $13 at $214.65 in Monday's session. The company will announce Q1 earnings before the bell on Tuesday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The issue has tumbled since a planned merger with Pfizer Inc (NYSE: PFE) was scrapped on April 5. The following day drop declined all the way to $236.55 and traded as low as $195.50 in before rebounding to close at $201.65.
The catalyst for today's rally besides some short covering ahead of the report is the announcement that a Phase III study for Ulipristal Acetate in the treatment of uterine fibroids met all co-primary and secondary endpoints.